Immune to Cancer: The CRI Blog
-
Sarcoma Awareness Month: Tackling Chordoma with Dr. Cassian Yee
CRI-Chordoma Foundation CLIP Investigator Dr. Cassian Yee is exploring how to design cell therapies for patients with…
-
ASCO21 Recap: Immunotherapy’s Continued Progress and Addressing Healthcare Disparities
ASCO21 highlighted the latest immunotherapy advances in checkpoint inhibition and cell therapies, and addressed disparities in healthcare.
-
Cell Therapy Development Lagged in 2020 But Is Gaining Ground Again, New CRI Report Shows
Cell therapy development lagged in 2020, but is gaining ground again, a new CRI report shows.
-
COVID-19’s Impact on Oncology Clinical Trials: A One-Year Follow-Up Analysis
A new CRI report highlights the impact of the COVID-19 pandemic on cancer clinical trials compared to…
-
Impacto de la pandemia de COVID-19 en los ensayos clínicos oncológicos: análisis de seguimiento a un año
Un nuevo informe del CRI destaca la repercusión de la pandemia de COVID-19 en los ensayos clínicos…
-
12 Challenges for 2021: Fundraising Ideas for Every Month of the Year
Commit to change in 2021 and advance cancer immunotherapy research. Get fundraising ideas for every month of…

Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.